Demonstrating faster, simpler, more cost-efficient NGS workflows that turn complex agrigenomics data into practical ...

Explore the groundbreaking AI genomics platform, Inference, launched by Variant Bio to enhance drug discovery using genetic ...

Cathie Wood is making a massive bet on gene editing, pouring $5.4 billion into companies like Beam Therapeutics while selling ...

As of Thursday, January 08, Standard BioTools Inc.’s LAB share price has surged by 11.72%, which has investors questioning if ...

Illumina, Inc. (NASDAQ: ILMN) today announced the release of Illumina Connected Multiomics, a powerful cloud-based research ...

What Happened? Shares of biotech company 10x Genomics (NASDAQ:TXG) jumped 2.5% in the afternoon session after several ...

Cathie Wood’s latest moves entering 2026 focused on early-stage biotechnology firms while cutting exposure to consumer ...

Illumina, whose EMEA head office is at Granta Park in Cambridge, has released Illumina Connected Multiomics, a powerful cloud ...

A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.

The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the ...

As of Thursday, January 08, Neogen Corporation’s NEOG share price has surged by 34.28%, which has investors questioning if ...

US firm, backed by Fosun and Tencent, expands research base in China as it develops an AI-powered drug-discovery tool.